The delay, narrowed approval, and extra study steps raise concerns about the status of and potential added requirements for other COVID vaccines.
Plaque growth can lead to a higher risk of heart attack, stroke, and other life-threatening cardiovascular events for as long as 1 year.
Post-exertional malaise, or exercise intolerance, was seen in 36% of those with long COVID.
Get weekly COVD-19 updates in your inbox.
Catch the latest episode!
Top COVID FAQs
By CIDRAP & other experts
Read all 7 reports
The high protection was found even amid high Alpha and Delta variant circulation.
Covaxin, made by Bharat Biotech, is an inactivated vaccine given in two doses 4 weeks apart.
COVID-19 didn't appear to spread efficiently within and among teams last fall.
Spanish, Italian, and UK physicians reported high levels of depression and anxiety during the first two waves of the COVID-19 pandemic, finds a study yesterday in PLOS One.
The ACIP recommendation now goes to CDC head Walensky for final approval.
A hybrid of natural and vaccine immunity may protect better against breakthrough infections.
Also, new CDC data show why immune-compromised people need an added COVID vaccine dose.
Two doses of the Pfizer/BioNTech and Moderna mRNA COVID-19 vaccines were 93% and 96% effective, respectively, in preventing severe, critical, or fatal disease caused by the highly transmissible Delta (B1617.2) variant, a study today in Nature Medicine finds.
"As we await CDC's decision, we are not waiting on operations or logistics."
The group agreed on a goal of vaccinating at least 70% of the world's population by the middle of next year.
